Mylan Pharmaceuticals Inc. et al. vs. Pfizer Inc.
Explore the PTAB proceeding IPR2018-01359 filed by Mylan Pharmaceuticals Inc. et al. on 2018-07-06. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2018-01359
Filing Date
2018-07-06
Accorded Filing Date
2018-07-06
Institution Decision Date
2018-10-11
Last Modified Date
2024-01-11
Proceeding Type
IPR
Termination Date
2018-10-11
Trial Status
Terminated
Parties & Counsel
Petitioner
Mylan Pharmaceuticals Inc. et al.
Represented By
Parmelee, Stevenet alPatent Owner / Respondent
Pfizer Inc.
Represented By
Maurer, Aaronet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
0 Total
Proceeding Status
Terminated
Administrative Patent Judges (APJ Panel)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 34462 | Bryan Zielinski | +1 858-755-5925 |
| 40784 | Jeffrey Rennecker | +1 858-622-8850 |
| 41213 | Jeffrey Myers | +1 212-733-5061 |
| 42640 | Suzanne Bates | +1 734-622-2658 |
| 43080 | Lisa Samuels | +1 860-686-0349 |
| 45051 | Chase Romick | +1 212-733-8054 |
| 46319 | Christian Smolizza | +1 212-733-9094 |
| 48032 | John Wichtowski | +1 860-715-6645 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
FlatWing Pharmaceuticals, LLC et al. v. Anacor Pharmaceuticals, Inc. et al.